Physician profile
Jessica S Kellerman
NPI 1588864706
$1,083.37
in general payments reported to CMS, 2019-2025
12 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $79.25 · 2021: $147 · 2022: $240 · 2023: $205 · 2024: $142 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $275.52 | 2020-2025 | Precision7, Total30 |
| Coopervision INC. | $232.12 | 2022-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $191.63 | 2022-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $129.55 | 2023-2025 | Infuse, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $59.71 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $53.53 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $34.33 | 2021-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $32.04 | 2021 | |
| Alimera Sciences, INC. | $24.36 | 2021 | |
| Horizon Therapeutics Plc | $19.48 | 2023 | Tepezza |
| Sight Sciences, INC. | $17.01 | 2023 | Tearcare System |
| Glaukos Corporation | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Kellerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.